MedTrace Logo

Furosemide Stress Test Guiding Initiation of Renal Replacement Therapy

NCT02730117 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2017-12-19

No results posted yet for this study

Summary

Does Early Initiation of Renal Replacement Therapy Have an Impact on 7-day Fluid Balance in Critically Ill Patients with Acute Kidney Injury with Positive Furosemide Stress Test?: a Multicenter Randomized Controlled Trial

Conditions

Interventions

DEVICE

Dialysis with continuous renal replacement therapy

Continuous renal replacement therapy is a form of 24-hour dialysis in the ICU

DEVICE

Mechanical ventilator

Invasive or noninvasive form of respiratory support

DRUG

Anti-Bacterial Agents

Antibacterial agents deemed appropriate by physicians in the ICU

DRUG

Vasopressors

Vasopressors such as Norepinephrine, dopamine, milrinone, dobutamine

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Nattachai Srisawat, MD · Excellence Center of Critical Care Nephrology, Chulalongkorn University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02730117 on ClinicalTrials.gov